WallStreetZenWallStreetZen

NYSEMKT: ASXC
Asensus Surgical Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ASXC past revenue growth

How has ASXC's revenue growth performed historically?
Company
21.02%
Industry
9.47%
Market
17.2%
ASXC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ASXC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ASXC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ASXC earnings and revenue history

Current Revenue
$8.6M
Current Earnings
-$78.4M
Current Profit Margin
-914.5%

ASXC Return on Equity

Current Company
-141.4%
Current Industry
10.5%
Current Market
188%
ASXC's Return on Equity (-141.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ASXC announces earnings.

ASXC Return on Assets

Current Company
-103%
Current Industry
5.3%
ASXC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ASXC Return on Capital Employed

Current Company
-168.15%
Current Industry
8.3%
ASXC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASXC vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ASXC$8.58M-$74.39M-$78.43M-18.67%N/A
AMIXN/AN/AN/AN/AN/A
NVNO$0.00-$22.97M-$23.52M-100.00%N/A
ELUT$24.75M-$28.08M-$37.66M-8.71%N/A
HYPR$11.03M-$43.18M-$44.24M+331.79%N/A
View Top Medical Device Stocks

ASXC earnings dates

Next earnings date
Jun 5, 2024

Asensus Surgical Earnings & Revenue FAQ

What were ASXC's earnings last quarter?

On Invalid Date, Asensus Surgical (NYSEMKT: ASXC) reported Q4 2023 earnings per share (EPS) of -$0.06, up 25% year over year. Total Asensus Surgical earnings for the quarter were -$17.24 million. In the same quarter last year, Asensus Surgical's earnings per share (EPS) was -$0.08.

If you're new to stock investing, here's how to buy Asensus Surgical stock.

What was ASXC's earnings growth in the past year?

As of Q2 2024, Asensus Surgical's earnings has grown year over year. Asensus Surgical's earnings in the past year totalled -$78.43 million.

What is ASXC's earnings date?

Asensus Surgical's earnings date is Invalid Date. Add ASXC to your watchlist to be reminded of ASXC's next earnings announcement.

What was ASXC's revenue last quarter?

On Invalid Date, Asensus Surgical (NYSEMKT: ASXC) reported Q4 2023 revenue of $5.43 million up 120.41% year over year. In the same quarter last year, Asensus Surgical's revenue was $2.46 million.

What was ASXC's revenue growth in the past year?

As of Q2 2024, Asensus Surgical's revenue has grown 21.02% year over year. This is 11.56 percentage points higher than the US Medical Devices industry revenue growth rate of 9.47%. Asensus Surgical's revenue in the past year totalled $8.58 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.